All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

URN to cite this document:: urn:nbn:de:bvb:355-epub-569097
DOI to cite this document:: 10.5283/epub.56909

Schons, Maximilian J. ; Caliebe, Amke ; Spinner, Christoph D. ; Classen, Annika Y.

; Pilgram, Lisa ; Ruethrich, Maria M. ; Rupp, Jan

; Nunes de Miranda, Susana M. ; Römmele, Christoph

; Vehreschild, Janne ; Jensen, Bjoern-Erik ; Vehreschild, Maria ; Degenhardt, Christian ; Borgmann, Stefan ; Hower, Martin ; Hanses, Frank

; Haselberger, Martina

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 29 Feb 2024 12:42

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Purpose Reported antibiotic use in coronavirus disease 2019 (COVID-19) is far higher than the actual rate of reported bacterial co- and superinfection. A better understanding of antibiotic therapy in COVID-19 is necessary. Methods 6457 SARS-CoV-2-infected cases, documented from March 18, 2020, until February 16, 2021, in the LEOSS cohort were analyzed. As primary endpoint, the correlation ...